Response to Comments: Genomic Sequence Analysis Panels in the Treatment of Solid Organ Neoplasms- Related to Genomic Sequence Analysis Panels in the Treatment of Solid Organ Neoplasms (L37810)

This document (A56216) is a response-to-comments notice concerning the Genomic Sequence Analysis Panels LCD (L37810) and does not itself establish clinical coverage criteria. The official notice period began February 14, 2019 and the final LCD determination became effective April 1, 2019; providers should consult LCD L37810 for specific indications, limitations, documentation, and frequency requirements.

"This document is a response to public/provider comments on LCD L37810 (Genomic Sequence Analysis Panels in the Treatment of Solid Organ Neoplasms) and does not itself define or change clinical cove..."

Sign up to see full coverage criteria, indications, and limitations.